Forte Biosciences, Inc. Common Stock (FBRX) is a publicly traded Healthcare sector company. As of July 9, 2026, FBRX trades at $32.00 with a market cap of $455.65M and a P/E ratio of -4.52. FBRX moved +48.27% today. Year to date, FBRX is -24.53%; over the trailing twelve months it is +64.90%. Its 52-week range spans $4.90 to $35.80. Analyst consensus is strong buy with an average price target of $63.00. Rallies surfaces FBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for FBRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $32.00 |
| Market Cap | $455.65M |
| P/E Ratio | -4.52 |
| EPS | $-4.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.80 |
| 52-Week Low | $4.90 |
| Volume | 2.65M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.71M |
| Net Income | $-69.38M |
| Gross Margin | 0.00% |
3 analysts cover FBRX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $63.00.